197 related articles for article (PubMed ID: 38189813)
21. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
Zhang QY; Men CJ; Ding XW
J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
Sun WM; Tao W; Li JC; Zhu DM; Miao Y
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
[TBL] [Abstract][Full Text] [Related]
23. LINC01433/miR-2116-3p/MYC Feedback Loop Promotes Cell Proliferation, Migration, and the Epithelial-Mesenchymal Transition in Breast Cancer.
Wu M; Wu W; Ding J; Yang J
Cancer Biother Radiopharm; 2019 Aug; 34(6):388-397. PubMed ID: 30939038
[No Abstract] [Full Text] [Related]
24. miR-381-3p suppresses breast cancer progression by inhibition of epithelial-mesenchymal transition.
Yu YZ; Mu Q; Ren Q; Xie LJ; Wang QT; Wang CP
World J Surg Oncol; 2021 Aug; 19(1):230. PubMed ID: 34362391
[TBL] [Abstract][Full Text] [Related]
25. MiR-337-3p suppresses migration and invasion of breast cancer cells by downregulating ESRP1.
Pan Y; Zhao Y; Lihui L; Xie Y; Zou Q
Acta Histochem; 2021 Oct; 123(7):151777. PubMed ID: 34481218
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
Fan X; Huang X; Li Z; Ma X
J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
[TBL] [Abstract][Full Text] [Related]
27. MiR-191-5p inhibits KLF6 to promote epithelial-mesenchymal transition in breast cancer.
Pan L; Liu W; Zhao H; Chen B; Yue X
Technol Health Care; 2023; 31(6):2251-2265. PubMed ID: 37545272
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-135 inhibits initiation of epithelial-mesenchymal transition in breast cancer by targeting ZNF217 and promoting m6A modification of NANOG.
Xu LM; Zhang J; Ma Y; Yuan YJ; Yu H; Wang J; Cao XC; Zhu L; Wang P
Oncogene; 2022 Mar; 41(12):1742-1751. PubMed ID: 35121826
[TBL] [Abstract][Full Text] [Related]
29. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Sun T; Song Y; Yu H; Luo X
Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
31. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
[TBL] [Abstract][Full Text] [Related]
32. MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7.
Xiao Y; Zhang SJ; Yan X; Wu C; Liu QW; Dong HX; Wang LJ; Hu Y
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5625-5635. PubMed ID: 34604955
[TBL] [Abstract][Full Text] [Related]
33. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
34. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
35. miR-1301-3p promotes invasion and migration and EMT progression in esophageal cancer by downregulating NBL1 expression.
Du J; Zhang S; Zhang X; Yang Z; Xue S; Xu G; Zheng B; Chen C
Thorac Cancer; 2023 Oct; 14(30):3032-3041. PubMed ID: 37680006
[TBL] [Abstract][Full Text] [Related]
36. Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.
Zhai D; Zhou Y; Kuang X; Shao F; Zhen T; Lin Y; Wang Q; Shao N
Int J Med Sci; 2023; 20(9):1152-1162. PubMed ID: 37575267
[No Abstract] [Full Text] [Related]
37. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
Chang S; Sun G; Zhang D; Li Q; Qian H
Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361
[TBL] [Abstract][Full Text] [Related]
38. miR-143-3p inhibits proliferation and invasion of hepatocellular carcinoma cells by regulating its target gene FGF1.
Peng J; Wu HJ; Zhang HF; Fang SQ; Zeng R
Clin Transl Oncol; 2021 Mar; 23(3):468-480. PubMed ID: 32617870
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
Zhao C; Ling X; Li X; Hou X; Zhao D
Breast Cancer; 2019 Nov; 26(6):817-825. PubMed ID: 31243644
[TBL] [Abstract][Full Text] [Related]
40. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
